Key Financial Data Of Reporting Company

TRANS GENIC GROUP INC. - Filing #7298255

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
6,311,881,000 JPY
13,083,458,000 JPY
6,377,299,000 JPY
Ordinary profit (loss)
-156,532,000 JPY
108,326,000 JPY
94,791,000 JPY
Net assets
5,753,984,000 JPY
5,998,464,000 JPY
6,119,746,000 JPY
Total assets
10,575,344,000 JPY
9,810,999,000 JPY
10,482,478,000 JPY
Basic earnings (loss) per share
-10.97
0.24
2.87
Diluted earnings per share
Equity-to-asset ratio
0.535 xbrli:pure
0.601 xbrli:pure
0.574 xbrli:pure
Net cash provided by (used in) operating activities
-421,145,000 JPY
-392,453,000 JPY
-365,546,000 JPY
Net cash provided by (used in) investing activities
-174,666,000 JPY
-280,928,000 JPY
-129,107,000 JPY
Net cash provided by (used in) financing activities
378,836,000 JPY
-342,689,000 JPY
-46,774,000 JPY
Cash and cash equivalents
2,244,975,000 JPY
2,466,101,000 JPY
2,920,760,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.